Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer
2nd Annual Tatar Cancer Symposium 2012 - Dr HudisПодробнее
Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast CancerПодробнее
Dr. Hurvitz on Neoadjuvant Therapy for HER2+ Breast CancerПодробнее
Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast CancerПодробнее
Neoadjuvant Treatment Strategies for HER2-Positive Breast CancerПодробнее
Dr. Tolaney on the Neoadjuvant Therapy for HER2-Positive Breast CancerПодробнее
Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее
Dr. Clifford A. Hudis on In-Breast Response Rates in Triple-Negative Breast CancerПодробнее
Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее
Treatment de-escalation and escalation strategies in HER2-positive breast cancerПодробнее
Neoadjuvant Therapy for HER2+ Breast CancerПодробнее
Dr. Hudis on the Challenges of TNBCПодробнее
Dr Nanda on Treatment De-Escalation in HER2+ Breast Cancer and TNBCПодробнее
Overview of Neoadjuvant Therapy in HER2+ Breast CancerПодробнее
Dr. Sanft on Treatment Options in HER2-Positive Breast CancerПодробнее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast CancerПодробнее
HER2DX and pCR in HER2-positive breast cancer: a combined analysis of 4 neoadjuvant studiesПодробнее
Dr. Tereffe on Treatment After Neoadjuvant Chemotherapy in Breast CancerПодробнее
